Comment on: COVID-19 vaccine-associated reactivation of uveitis.
作者信息
Sanjay Srinivasan, Kawali Ankush
机构信息
Department of Uvea and Ocular Immunology, Narayana Nethralaya, Bengaluru, Karnataka, India.
出版信息
Indian J Ophthalmol. 2022 Jan;70(1):342-343. doi: 10.4103/ijo.IJO_2741_21.
Abstract
摘要
相似文献
1
Comment on: COVID-19 vaccine-associated reactivation of uveitis.关于《新型冠状病毒肺炎疫苗相关的葡萄膜炎再激活》的评论
Indian J Ophthalmol. 2022 Jan;70(1):342-343. doi: 10.4103/ijo.IJO_2741_21.
2
COVID-19 vaccine-associated reactivation of uveitis.新型冠状病毒肺炎疫苗相关的葡萄膜炎再激活
Indian J Ophthalmol. 2021 Oct;69(10):2899-2900. doi: 10.4103/ijo.IJO_1435_21.
3
Bilateral uveitis after inoculation with COVID-19 vaccine: A case report.接种 COVID-19 疫苗后双侧虹膜炎：一例报告。
Int J Infect Dis. 2021 Dec;113:116-118. doi: 10.1016/j.ijid.2021.09.075. Epub 2021 Sep 30.
4
SARS CoV-2 vaccine AND rituximab. Comment on: "SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response" by Verhoeven Joint Bone Spine. 2021;88:105258.严重急性呼吸综合征冠状病毒2疫苗与利妥昔单抗。评论：Verhoeven等人在《关节与脊柱》杂志上发表的“严重急性呼吸综合征冠状病毒2疫苗与利妥昔单抗，时机可能是获得更好疫苗反应的关键”。2021年；88:105258 。
Joint Bone Spine. 2022 Jan;89(1):105281. doi: 10.1016/j.jbspin.2021.105281. Epub 2021 Sep 29.
5
SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150.严重急性呼吸综合征冠状病毒2、风湿性多肌痛和巨细胞动脉炎：新冠疫苗接种会成为诱因吗？对曼佐等人所著《严重急性呼吸综合征冠状病毒2会引发风湿性多肌痛复发吗？》的评论。《关节与脊柱》2021年；88:105150
Joint Bone Spine. 2022 Jan;89(1):105282. doi: 10.1016/j.jbspin.2021.105282. Epub 2021 Sep 29.
6
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?接种 bnt162b2 疫苗后发生前葡萄膜炎：这仅仅是巧合吗？
Int J Infect Dis. 2021 Sep;110:95-97. doi: 10.1016/j.ijid.2021.07.035. Epub 2021 Jul 18.
7
Comment on: "Willingness to Pay for a COVID-19 Vaccine".关于《为新冠疫苗支付意愿》的评论
Appl Health Econ Health Policy. 2021 Jul;19(4):619-621. doi: 10.1007/s40258-021-00656-2. Epub 2021 May 11.
8
Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".回复：“对《2019冠状病毒病（COVID-19）疫苗接种后发生自身免疫性肝炎：因果关系还是意外？》的评论”。
J Hepatol. 2021 Oct;75(4):996-997. doi: 10.1016/j.jhep.2021.06.008. Epub 2021 Jun 17.
9
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
10
Getting a Vaccine, Jab, or Vax Is More Than a Regular Expression. Comment on "COVID-19 Vaccine-Related Discussion on Twitter: Topic Modeling and Sentiment Analysis".接种疫苗不仅仅是一个正则表达式。评《推特上与新冠疫苗相关的讨论：主题建模与情感分析》
J Med Internet Res. 2022 Feb 23;24(2):e31978. doi: 10.2196/31978.
引用本文的文献
1
COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis.COVID-19 疫苗接种、登革热肝炎与复发性单侧前葡萄膜炎。
Indian J Ophthalmol. 2023 May;71(5):2269-2272. doi: 10.4103/ijo.IJO_2064_22.
2
COVID-19 vaccination and recurrent anterior uveitis.COVID-19 疫苗接种与复发性前葡萄膜炎。
Indian J Ophthalmol. 2022 Dec;70(12):4445-4448. doi: 10.4103/ijo.IJO_1089_22.
本文引用的文献
1
COVID-19 vaccine-associated reactivation of uveitis.新型冠状病毒肺炎疫苗相关的葡萄膜炎再激活
Indian J Ophthalmol. 2021 Oct;69(10):2899-2900. doi: 10.4103/ijo.IJO_1435_21.
2
Ocular Adverse Events After COVID-19 Vaccination.接种 COVID-19 疫苗后的眼部不良反应。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1216-1224. doi: 10.1080/09273948.2021.1976221. Epub 2021 Sep 24.
3
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.疫苗接种后 COVID-19 疫苗诱导的免疫性血栓性血小板减少症和脑静脉窦血栓形成：系统评价。
J Neurol Sci. 2021 Sep 15;428:117607. doi: 10.1016/j.jns.2021.117607. Epub 2021 Aug 3.
4
"Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis".新冠病毒病（COVID-19）后静止性单侧前葡萄膜炎的再激活
SN Compr Clin Med. 2021;3(9):1843-1847. doi: 10.1007/s42399-021-00985-2. Epub 2021 Jun 7.
5
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.27名受试者在接种mRNA/DNA新冠病毒疫苗后出现免疫介导疾病发作或新发疾病
Vaccines (Basel). 2021 Apr 29;9(5):435. doi: 10.3390/vaccines9050435.
6
Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic.新冠疫情期间封锁措施对一名因单侧HLA-B27相关性葡萄膜炎接受免疫抑制治疗患者的影响。
Indian J Ophthalmol. 2021 May;69(5):1351-1353. doi: 10.4103/ijo.IJO_3504_20.
7
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗：免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
8
The immunology of COVID-19: is immune modulation an option for treatment?新型冠状病毒肺炎的免疫学：免疫调节是一种治疗选择吗？
Lancet Rheumatol. 2020 Jul;2(7):e428-e436. doi: 10.1016/S2665-9913(20)30120-X. Epub 2020 May 20.
9
Impact of COVID-19 on a tertiary eye hospital.2019冠状病毒病对一家三级眼科医院的影响。
Indian J Ophthalmol. 2020 Jul;68(7):1485-1486. doi: 10.4103/ijo.IJO_921_20.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件